首页 > 最新文献

Anesthesia and pain medicine最新文献

英文 中文
Modified submental intubation techniques for maxillofacial surgery - A report of five cases. 改良的颏下插管技术在颌面外科中的应用——附5例报告。
Pub Date : 2022-07-01 Epub Date: 2022-06-30 DOI: 10.17085/apm.21124
Yeong-Gwan Jeon, Chunui Lee, Dongeui Hong, Younghyun Jin, Hyun Kyo Lim

Background: Submental intubation has been the recommended airway management procedure for maxillofacial surgery since proposed by Altemir in 1986. We adopted various submental intubation modifications based on modified intubation protocols and report on the effectiveness and problems of each modified method.

Case: Among a total of 13 submental intubation cases during the last five years, five representative methods are described. The proximal end of the endotracheal tube was protected by a nelaton catheter in case 1, by a suction connector in case 2, and by a dental needle cap in case 3. In case 4, a nasal speculum was used to expand a single route, and in case 5, a laparoscopic trocar was used to secure a single route.

Conclusions: Use of a laparoscopic trocar might be the most effective way to obtain a single submental route. However, considering cost, use of a nasal speculum is also an effective suboptimal solution.

背景:自1986年Altemir提出颏下插管以来,颏下插管一直是颌面外科推荐的气道管理方法。我们根据修改后的插管方案,采用了各种颏下插管修改方法,并报告了每种修改方法的有效性和存在的问题。案例:在近五年来共13例精神下插管病例中,描述了五种具有代表性的方法。在病例1中,气管内管的近端由nelaton导管保护,在病例2中由吸引连接器保护,在病例3中由牙科针帽保护。在病例4中,使用鼻窥镜扩展单一通道,在病例5中,使用腹腔镜套管针固定单一通道。结论:使用腹腔镜套管针可能是获得单一颏下路径的最有效方法。然而,考虑到成本,使用鼻窥器也是一种有效的次优解决方案。
{"title":"Modified submental intubation techniques for maxillofacial surgery - A report of five cases.","authors":"Yeong-Gwan Jeon,&nbsp;Chunui Lee,&nbsp;Dongeui Hong,&nbsp;Younghyun Jin,&nbsp;Hyun Kyo Lim","doi":"10.17085/apm.21124","DOIUrl":"https://doi.org/10.17085/apm.21124","url":null,"abstract":"<p><strong>Background: </strong>Submental intubation has been the recommended airway management procedure for maxillofacial surgery since proposed by Altemir in 1986. We adopted various submental intubation modifications based on modified intubation protocols and report on the effectiveness and problems of each modified method.</p><p><strong>Case: </strong>Among a total of 13 submental intubation cases during the last five years, five representative methods are described. The proximal end of the endotracheal tube was protected by a nelaton catheter in case 1, by a suction connector in case 2, and by a dental needle cap in case 3. In case 4, a nasal speculum was used to expand a single route, and in case 5, a laparoscopic trocar was used to secure a single route.</p><p><strong>Conclusions: </strong>Use of a laparoscopic trocar might be the most effective way to obtain a single submental route. However, considering cost, use of a nasal speculum is also an effective suboptimal solution.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"331-337"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1d/81/apm-21124.PMC9346202.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40576570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
General anesthesia for cesarean section: are we doing it well? 剖宫产术的全身麻醉:我们做得好吗?
Pub Date : 2022-07-01 Epub Date: 2022-07-26 DOI: 10.17085/apm.22196
Sung Uk Choi

Korea has a higher rate of cesarean sections under general anesthesia than in other countries. Neuraxial anesthesia is the gold standard for a cesarean section, but there are some cases in which general anesthesia is inevitable. Therefore, obstetric anesthesiologists should be familiar in performing general anesthesia for cesarean section. Rapid-sequence induction and intubation with cricoid pressure using thiopental-succinylcholine have been the standard for cesarean section under general anesthesia for a long time. Recently, with the introduction of new drugs (propofol, rocuronium, and sugammadex) and equipments (videolaryngoscopy and supraglottic airways), anesthesia methods have also gradually changed. Pursuing the safety of obstetric patients and anesthesiologists at the same time, this review will help update the knowledge or training in performing general anesthesia for cesarean section.

在韩国,全身麻醉下剖宫产的比率比其他国家高。轴向麻醉是剖宫产的黄金标准,但在某些情况下,全身麻醉是不可避免的。因此,产科麻醉师应熟悉剖宫产术的全身麻醉。长期以来,硫喷妥-琥珀酰胆碱快速序贯诱导和环状压力插管是全麻剖宫产术的标准。近年来,随着新药物(异丙酚、罗库溴铵、糖马德)和新设备(视频喉镜、声门上气道)的引入,麻醉方法也逐渐发生了变化。在保证产科患者和麻醉医师安全的同时,本综述将有助于更新剖宫产全麻的知识或培训。
{"title":"General anesthesia for cesarean section: are we doing it well?","authors":"Sung Uk Choi","doi":"10.17085/apm.22196","DOIUrl":"https://doi.org/10.17085/apm.22196","url":null,"abstract":"<p><p>Korea has a higher rate of cesarean sections under general anesthesia than in other countries. Neuraxial anesthesia is the gold standard for a cesarean section, but there are some cases in which general anesthesia is inevitable. Therefore, obstetric anesthesiologists should be familiar in performing general anesthesia for cesarean section. Rapid-sequence induction and intubation with cricoid pressure using thiopental-succinylcholine have been the standard for cesarean section under general anesthesia for a long time. Recently, with the introduction of new drugs (propofol, rocuronium, and sugammadex) and equipments (videolaryngoscopy and supraglottic airways), anesthesia methods have also gradually changed. Pursuing the safety of obstetric patients and anesthesiologists at the same time, this review will help update the knowledge or training in performing general anesthesia for cesarean section.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"256-261"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c6/81/apm-22196.PMC9346210.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40687368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Comparative evaluation of propofol versus dexmedetomidine infusion for hypotensive anesthesia during functional endoscopic sinus surgery: a prospective randomized trial. 异丙酚与右美托咪定在功能性内窥镜鼻窦手术中降压麻醉的比较评价:一项前瞻性随机试验。
Pub Date : 2022-07-01 Epub Date: 2022-06-14 DOI: 10.17085/apm.21118
Kewal Krishan Gupta, Vandana Kumari, Sarvjeet Kaur, Amanjot Singh

Background: During functional endoscopic sinus surgery (FESS), intranasal bleeding affects operative field visibility and increases the frequency of complications. Therefore, hypotensive anesthesia is a widely used technique to improve surgical outcomes. This study aimed to compare the efficacy of propofol and dexmedetomidine infusion for hypotensive anesthesia in patients undergoing FESS.

Methods: This prospective randomized trial was conducted in 80 adult patients who were scheduled for FESS under general anesthesia. Patients were randomly divided into two groups: group P (n = 40) received propofol infusion of 100-200 µg/kg/min and group D (n = 40) received dexmedetomidine infusion with a loading dose of 1 µg/kg over 10 min after induction, followed by maintenance infusion of 0.4-0.8 µg/kg/h. Intraoperative blood loss, quality of the surgical field (Fromme- Boezaart scale), hemodynamic control, and patient recovery were recorded. Statistical analysis was performed using Student's t-test, chi-square test, and Mann-Whitney U test.

Results: The mean arterial pressure and heart rate were significantly lower in group D throughout the surgery than in group P. Blood loss was significantly higher in group P (100.73 ± 18.12 ml) than in group D (85.70 ± 18.56 ml). The average number of patients with Fromme's score 1/2/3 was comparable between the groups. Intraoperatively, only one incidence of bradycardia and hypotension was observed in group D (2.5%) compared to group P.

Conclusions: Both dexmedetomidine and propofol are efficacious and safe drugs for facilitating controlled hypotension during FESS; however, dexmedetomidine provides better hemodynamic control and is associated with lesser blood loss without any significant adverse effects.

背景:在功能性内窥镜鼻窦手术(FESS)中,鼻内出血影响手术视野的可见度并增加并发症的发生频率。因此,低血压麻醉是一种广泛使用的技术,以提高手术效果。本研究旨在比较异丙酚和右美托咪定输注在FESS患者中降压麻醉的效果。方法:本前瞻性随机试验在80例全麻下计划行FESS的成年患者中进行。将患者随机分为两组:P组(n = 40)给予异丙酚输注100 ~ 200µg/kg/min; D组(n = 40)给予右美托咪定输注,诱导后10 min内负荷剂量为1µg/kg,维持输注0.4 ~ 0.8µg/kg/h。记录术中出血量、术野质量(Fromme- Boezaart量表)、血流动力学控制和患者恢复情况。统计学分析采用学生t检验、卡方检验和Mann-Whitney U检验。结果:术中D组平均动脉压、心率明显低于P组,出血量(100.73±18.12 ml)明显高于D组(85.70±18.56 ml)。Fromme评分1/2/3的患者平均人数在两组间具有可比性。与p组相比,D组术中仅有1例心动过缓和低血压发生率(2.5%)。结论:右美托咪定和异丙酚均是FESS术中有效、安全的降压药物;然而,右美托咪定提供更好的血流动力学控制,与较少的失血量相关,没有任何明显的不良反应。
{"title":"Comparative evaluation of propofol versus dexmedetomidine infusion for hypotensive anesthesia during functional endoscopic sinus surgery: a prospective randomized trial.","authors":"Kewal Krishan Gupta,&nbsp;Vandana Kumari,&nbsp;Sarvjeet Kaur,&nbsp;Amanjot Singh","doi":"10.17085/apm.21118","DOIUrl":"https://doi.org/10.17085/apm.21118","url":null,"abstract":"<p><strong>Background: </strong>During functional endoscopic sinus surgery (FESS), intranasal bleeding affects operative field visibility and increases the frequency of complications. Therefore, hypotensive anesthesia is a widely used technique to improve surgical outcomes. This study aimed to compare the efficacy of propofol and dexmedetomidine infusion for hypotensive anesthesia in patients undergoing FESS.</p><p><strong>Methods: </strong>This prospective randomized trial was conducted in 80 adult patients who were scheduled for FESS under general anesthesia. Patients were randomly divided into two groups: group P (n = 40) received propofol infusion of 100-200 µg/kg/min and group D (n = 40) received dexmedetomidine infusion with a loading dose of 1 µg/kg over 10 min after induction, followed by maintenance infusion of 0.4-0.8 µg/kg/h. Intraoperative blood loss, quality of the surgical field (Fromme- Boezaart scale), hemodynamic control, and patient recovery were recorded. Statistical analysis was performed using Student's t-test, chi-square test, and Mann-Whitney U test.</p><p><strong>Results: </strong>The mean arterial pressure and heart rate were significantly lower in group D throughout the surgery than in group P. Blood loss was significantly higher in group P (100.73 ± 18.12 ml) than in group D (85.70 ± 18.56 ml). The average number of patients with Fromme's score 1/2/3 was comparable between the groups. Intraoperatively, only one incidence of bradycardia and hypotension was observed in group D (2.5%) compared to group P.</p><p><strong>Conclusions: </strong>Both dexmedetomidine and propofol are efficacious and safe drugs for facilitating controlled hypotension during FESS; however, dexmedetomidine provides better hemodynamic control and is associated with lesser blood loss without any significant adverse effects.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"271-279"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f6/27/apm-21118.PMC9346206.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40687370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Effect of intravenous magnesium on postoperative pain control for major abdominal surgery: a randomized double-blinded study. 静脉注射镁对腹部大手术术后疼痛控制的影响:一项随机双盲研究。
Pub Date : 2022-07-01 Epub Date: 2022-07-28 DOI: 10.17085/apm.22156
Arash Peivandi Yazdi, Mehrdad Esmaeeli, Mehryar Taghavi Gilani

Background: This study aimed to evaluate the postoperative analgesic effect of magnesium sulfate during abdominal surgery.

Methods: This randomized double-blinded study involved 84 patients candidates for abdominal surgery into two same groups. In the magnesium group, at first 25 mg/kg/1 h magnesium sulfate; and then, 100 mg/kg/24 h was infused in the intensive care unit. The pain intensity (the primary outcome), was assessed using the numeric rating scale (NRS) every 3 h. If the NRS was > 3, morphine (as a secondary outcome) was used and evaluated. The results were analyzed using SPSS ver. 19 software, and statistical significance was set at P < 0.05.

Results: Demographic parameters were similar between the groups. The pain intensity were similar at first and then at the third hour in both groups (P = 0.393 and P = 0.172, respectively), but thereafter between 6 and 24 h, the pain severity was significantly lower in the magnesium group (4.4 ± 1.3 in the control and 3.34 ± 1 in the magnesium group at 6th hour and P = 0.001). In addition, morphine intake in the first 24 h in the two groups had a significant difference, with 13.2 ± 5.7 mg in control group and 8 ± 3.5 mg in magnesium group (P = 0.001).

Conclusions: In this study, intravenous magnesium sulfate after abdominal surgeries for 24 h resolved the pain intensity after six hours and reduced morphine dosage.

背景:本研究旨在评价硫酸镁在腹部手术术后的镇痛效果。方法:这项随机双盲研究将84例腹部手术患者分为两组。镁组,初始硫酸镁25 mg/kg/1 h;然后在重症监护室输注100 mg/kg/24 h。疼痛强度(主要结果)每3小时用数值评定量表(NRS)进行评估。如果NRS > 3,则使用吗啡(作为次要结果)进行评估。采用SPSS统计软件对结果进行分析。19软件,P < 0.05有统计学意义。结果:组间人口学参数相似。两组患者第1 h和第3 h疼痛强度相似(P = 0.393和P = 0.172),但此后6 ~ 24 h,镁组疼痛程度明显降低(对照组4.4±1.3,镁组第6 h疼痛程度为3.34±1,P = 0.001)。另外,两组患者治疗前24 h吗啡摄取量差异有统计学意义,对照组为13.2±5.7 mg,镁组为8±3.5 mg (P = 0.001)。结论:在本研究中,腹腔手术后24 h静脉注射硫酸镁可缓解术后6 h疼痛强度,减少吗啡用量。
{"title":"Effect of intravenous magnesium on postoperative pain control for major abdominal surgery: a randomized double-blinded study.","authors":"Arash Peivandi Yazdi,&nbsp;Mehrdad Esmaeeli,&nbsp;Mehryar Taghavi Gilani","doi":"10.17085/apm.22156","DOIUrl":"https://doi.org/10.17085/apm.22156","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to evaluate the postoperative analgesic effect of magnesium sulfate during abdominal surgery.</p><p><strong>Methods: </strong>This randomized double-blinded study involved 84 patients candidates for abdominal surgery into two same groups. In the magnesium group, at first 25 mg/kg/1 h magnesium sulfate; and then, 100 mg/kg/24 h was infused in the intensive care unit. The pain intensity (the primary outcome), was assessed using the numeric rating scale (NRS) every 3 h. If the NRS was > 3, morphine (as a secondary outcome) was used and evaluated. The results were analyzed using SPSS ver. 19 software, and statistical significance was set at P < 0.05.</p><p><strong>Results: </strong>Demographic parameters were similar between the groups. The pain intensity were similar at first and then at the third hour in both groups (P = 0.393 and P = 0.172, respectively), but thereafter between 6 and 24 h, the pain severity was significantly lower in the magnesium group (4.4 ± 1.3 in the control and 3.34 ± 1 in the magnesium group at 6th hour and P = 0.001). In addition, morphine intake in the first 24 h in the two groups had a significant difference, with 13.2 ± 5.7 mg in control group and 8 ± 3.5 mg in magnesium group (P = 0.001).</p><p><strong>Conclusions: </strong>In this study, intravenous magnesium sulfate after abdominal surgeries for 24 h resolved the pain intensity after six hours and reduced morphine dosage.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"280-285"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/79/78/apm-22156.PMC9346203.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40687371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Sugammadex in pediatric patients. 糖玛德在儿科患者中的应用
Pub Date : 2022-07-01 Epub Date: 2022-07-22 DOI: 10.17085/apm.22159
Jae Moon Choi, Hong Seuk Yang
TO THE EDITOR: In South Korea, sugammadex has begun to be clinically used as an antagonist of nondepolarizing neuromuscular blockers since 2013 and is approved for use in pediatric patients above 2 years of age. There are many reports on the usefulness of sugammadex in pediatric patients. We read with great interest the paper titled “The use of sugammadex in an infant with prolonged neuromuscular blockade A case report -” [1]. However, we have some concerns that we would like to discuss. First, the authors administered neostigmine twice without anticholinergics. We assume that this was probably due to the atropine administered during the pre-induction period. However, concomitant administration of anticholinesterase and anticholinergics is not solely due to increases in the heart rate [2]. Second, the body temperature of the neuromuscular monitoring site should be well-maintained because hypothermia at the measurement site can interfere with mechanomyographic and acceleromyographic recordings. As an example, one study reported that the twitch tension of the adductor pollicis decreased by 16% per degree when the muscle temperature fell below 35.2°C [3]. Third, when the two post-tetanic counts were measured, sugammadex 25 mg (more than 4.6 mg/kg) was administered. Sugammadex is not approved for children under 2 years of age in South Korea or in other countries, and adverse events of sugammadex such as hypersensitivity tend to be dose-proportional [4]. Although the waiting time for recovery may be longer, careful administration of small doses may be more well-tolerated [5]. Lastly, during the 90-min period of emergence, it is likely that the patient would have struggled even if he was not able to move. There would have been various symptoms and signs that the patient had regained consciousness and experienced pain. Medications for pain relief and sedation had to be administered.
{"title":"Sugammadex in pediatric patients.","authors":"Jae Moon Choi,&nbsp;Hong Seuk Yang","doi":"10.17085/apm.22159","DOIUrl":"https://doi.org/10.17085/apm.22159","url":null,"abstract":"TO THE EDITOR: In South Korea, sugammadex has begun to be clinically used as an antagonist of nondepolarizing neuromuscular blockers since 2013 and is approved for use in pediatric patients above 2 years of age. There are many reports on the usefulness of sugammadex in pediatric patients. We read with great interest the paper titled “The use of sugammadex in an infant with prolonged neuromuscular blockade A case report -” [1]. However, we have some concerns that we would like to discuss. First, the authors administered neostigmine twice without anticholinergics. We assume that this was probably due to the atropine administered during the pre-induction period. However, concomitant administration of anticholinesterase and anticholinergics is not solely due to increases in the heart rate [2]. Second, the body temperature of the neuromuscular monitoring site should be well-maintained because hypothermia at the measurement site can interfere with mechanomyographic and acceleromyographic recordings. As an example, one study reported that the twitch tension of the adductor pollicis decreased by 16% per degree when the muscle temperature fell below 35.2°C [3]. Third, when the two post-tetanic counts were measured, sugammadex 25 mg (more than 4.6 mg/kg) was administered. Sugammadex is not approved for children under 2 years of age in South Korea or in other countries, and adverse events of sugammadex such as hypersensitivity tend to be dose-proportional [4]. Although the waiting time for recovery may be longer, careful administration of small doses may be more well-tolerated [5]. Lastly, during the 90-min period of emergence, it is likely that the patient would have struggled even if he was not able to move. There would have been various symptoms and signs that the patient had regained consciousness and experienced pain. Medications for pain relief and sedation had to be administered.","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"340"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/88/54/apm-22159.PMC9346208.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40576572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum: Advantages and pitfalls of clinical application of sugammadex. 勘误:临床应用sugammadex的优点和缺陷。
Pub Date : 2022-07-01 Epub Date: 2022-07-31 DOI: 10.17085/apm.19099.e1
Hyung Young Lee, Ki Tae Jung
{"title":"Corrigendum: Advantages and pitfalls of clinical application of sugammadex.","authors":"Hyung Young Lee,&nbsp;Ki Tae Jung","doi":"10.17085/apm.19099.e1","DOIUrl":"https://doi.org/10.17085/apm.19099.e1","url":null,"abstract":"","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"341"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/85/9c/apm-19099-e1.PMC9346205.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40576573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improvement of compliance to the Portland intensive insulin therapy during liver transplantation after introducing an application software: a retrospective single center cohort study. 引入应用软件后肝移植期间波特兰强化胰岛素治疗依从性的改善:一项回顾性单中心队列研究
Pub Date : 2022-07-01 Epub Date: 2022-07-26 DOI: 10.17085/apm.22136
Young Woong Choi, Sangbin Han, Justin S Ko, Su Nam Lee, Mi Sook Gwak, Gaab Soo Kim

Background: The Portland intensive insulin therapy effectively controls acute hyperglycemic change after graft reperfusion during liver transplantation. However, the time-consuming sophistication acts as a barrier leading to misinterpretation and decreasing compliance to the protocol; thus, we newly introduced an application software "Insulin protocol calculator" which automatically calculates therapeutic bolus/continuous insulin doses based on the Portland protocol.

Methods: Of 144 patients who underwent liver transplantation, 74 patients were treated before the introduction of "Insulin protocol calculator" by using a paper manual, and 70 patients were treated by using the application. Compliance was defined as the proportion of patients treated with exact bolus/continuous insulin dose according to the Portland protocol.

Results: Compliance was significantly greater in app group than in paper group regarding bolus dose (94.5% and 86.9%, P < 0.001), continuous dose (88.9% and 77.3%, P = 0.001), and both doses (86.6% and 73.8%, P < 0.001). Blood glucose concentration was significantly lower in app group at 3 h (125 ± 17 mg/dl vs. 136 ± 19 mg/dl, P = 0.014) and 4 h (135 ± 22 mg/dl vs. 115 ± 15 mg/dl, P = 0.029) after graft reperfusion. Acute hyperglycemic change during 30 min was more prominent in app group while hyperglycemia incidence was 71.4% vs. 54.1% (P = 0.031). However, hyperglycemia risk was comparable at 2 h (31.4% vs. 31.1%, P = 0.964), and even insignificantly lower in app group at 3 h (7.1% vs. 19.5%, P = 0.184).

Conclusions: Compliance to the Portland protocol was significantly improved after introducing the application software; post-reperfusion hyperglycemia was better controlled. "Insulin protocol calculator" is cost-effective and time-saving with potential clinical benefits.

背景:波特兰强化胰岛素治疗可有效控制肝移植再灌注后的急性高血糖改变。然而,耗时的复杂性成为导致误解和降低对协议的遵守的障碍;因此,我们新推出了一款应用软件“胰岛素方案计算器”,它可以根据波特兰方案自动计算治疗丸/连续胰岛素剂量。方法:144例肝移植患者中,74例患者在引入“胰岛素方案计算器”前采用纸质手册进行治疗,70例患者采用应用程序进行治疗。依从性定义为根据波特兰方案接受精确的胰岛素丸/连续剂量治疗的患者比例。结果:应用程序组在丸给药(94.5%和86.9%,P < 0.001)、连续给药(88.9%和77.3%,P = 0.001)和两种给药(86.6%和73.8%,P < 0.001)方面的依从性均显著高于纸给药组。app组在移植物再灌注后3 h(125±17 mg/dl比136±19 mg/dl, P = 0.014)和4 h(135±22 mg/dl比115±15 mg/dl, P = 0.029)血糖浓度显著降低。app组30min急性高血糖变化更明显,高血糖发生率分别为71.4%和54.1% (P = 0.031)。然而,在2 h时,app组的高血糖风险相当(31.4%比31.1%,P = 0.964),甚至在3 h时,app组的高血糖风险更低(7.1%比19.5%,P = 0.184)。结论:引入应用软件后,患者对Portland协议的依从性明显提高;再灌注后高血糖得到较好控制。“胰岛素方案计算器”具有成本效益和节省时间的潜在临床效益。
{"title":"Improvement of compliance to the Portland intensive insulin therapy during liver transplantation after introducing an application software: a retrospective single center cohort study.","authors":"Young Woong Choi,&nbsp;Sangbin Han,&nbsp;Justin S Ko,&nbsp;Su Nam Lee,&nbsp;Mi Sook Gwak,&nbsp;Gaab Soo Kim","doi":"10.17085/apm.22136","DOIUrl":"https://doi.org/10.17085/apm.22136","url":null,"abstract":"<p><strong>Background: </strong>The Portland intensive insulin therapy effectively controls acute hyperglycemic change after graft reperfusion during liver transplantation. However, the time-consuming sophistication acts as a barrier leading to misinterpretation and decreasing compliance to the protocol; thus, we newly introduced an application software \"Insulin protocol calculator\" which automatically calculates therapeutic bolus/continuous insulin doses based on the Portland protocol.</p><p><strong>Methods: </strong>Of 144 patients who underwent liver transplantation, 74 patients were treated before the introduction of \"Insulin protocol calculator\" by using a paper manual, and 70 patients were treated by using the application. Compliance was defined as the proportion of patients treated with exact bolus/continuous insulin dose according to the Portland protocol.</p><p><strong>Results: </strong>Compliance was significantly greater in app group than in paper group regarding bolus dose (94.5% and 86.9%, P < 0.001), continuous dose (88.9% and 77.3%, P = 0.001), and both doses (86.6% and 73.8%, P < 0.001). Blood glucose concentration was significantly lower in app group at 3 h (125 ± 17 mg/dl vs. 136 ± 19 mg/dl, P = 0.014) and 4 h (135 ± 22 mg/dl vs. 115 ± 15 mg/dl, P = 0.029) after graft reperfusion. Acute hyperglycemic change during 30 min was more prominent in app group while hyperglycemia incidence was 71.4% vs. 54.1% (P = 0.031). However, hyperglycemia risk was comparable at 2 h (31.4% vs. 31.1%, P = 0.964), and even insignificantly lower in app group at 3 h (7.1% vs. 19.5%, P = 0.184).</p><p><strong>Conclusions: </strong>Compliance to the Portland protocol was significantly improved after introducing the application software; post-reperfusion hyperglycemia was better controlled. \"Insulin protocol calculator\" is cost-effective and time-saving with potential clinical benefits.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"312-319"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a1/d6/apm-22136.PMC9346209.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40576568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hyperekplexia with congenital heart disease: anesthetic concerns and management. 先天性心脏病伴高臂丛症:麻醉问题及处理
Pub Date : 2022-07-01 Epub Date: 2022-07-05 DOI: 10.17085/apm.22173
Manbir Kaur, Raksha Vyas, Tanvi Meshram, Pradeep Bhatia
disease, is a rare genetic neurological disorder that primarily affects infants and is characterized by excessive blinking of eyes or body spasms in response to sudden unexpected auditory or tactile stimulation. Symptoms include extreme muscle tension (stiffness or hypertonia) [1]. Hyperekplexia is usually inherited as an autosomal dominant trait, but autosomal recessive or, rarely, X-linked inheritance may also occur [2]. Mutations in GLRA1, SLC6A5, GLRB, GPHN, and ARHGEF9 (X-linked) have been associated with these conditions. Hyperekplexia 1 is caused by a mutation in GLRA 1 gene [3]. Delayed developmental milestones or learning difficulties can be observed in some children. Congenital disabilities leading to dysfunction of glycinergic inhibitory transmission are seen in hereditary hyperekplexia [4,5]. They are frequently associated with inguinal, umbilical, or epigastric hernias. As a rare disease, limited literature is available regarding anesthetic management in such cases, primarily when associated with congenital heart disease (CHD). Here, we discuss the successful management of a hyperekplexic child with CHD. Written informed consent to publish this case was obtained from the patient’s legal guardian. A 1-year-old child weighing 9 kg was scheduled for a right inguinal hernia repair surgery. At presentation, the patient had dysmorphic facial features (short nose, retrognathia, anteverted nares, and long philtrum) (Fig. 1). His medical history suggested that he was born by caesarean section (because of thick meconium-stained liquor). The patient’s birth history was uneventful. However, a few hours after birth, he presented with a flexed posture, brisk reflexes, and an exaggerated startle response and was diagnosed with hyperekplexia. At one month of age, he developed global hypertonia, and had delayed development. Electroencephalography revealed interictal epileptiform discharges originating from the left posterior head region. Electromyography revealed a myopathic potential. Magnetic resonance imaging results Letter to the Editor Anesth Pain Med 2022;17:338-339 https://doi.org/10.17085/apm.22173 pISSN 1975-5171 • eISSN 2383-7977
{"title":"Hyperekplexia with congenital heart disease: anesthetic concerns and management.","authors":"Manbir Kaur,&nbsp;Raksha Vyas,&nbsp;Tanvi Meshram,&nbsp;Pradeep Bhatia","doi":"10.17085/apm.22173","DOIUrl":"https://doi.org/10.17085/apm.22173","url":null,"abstract":"disease, is a rare genetic neurological disorder that primarily affects infants and is characterized by excessive blinking of eyes or body spasms in response to sudden unexpected auditory or tactile stimulation. Symptoms include extreme muscle tension (stiffness or hypertonia) [1]. Hyperekplexia is usually inherited as an autosomal dominant trait, but autosomal recessive or, rarely, X-linked inheritance may also occur [2]. Mutations in GLRA1, SLC6A5, GLRB, GPHN, and ARHGEF9 (X-linked) have been associated with these conditions. Hyperekplexia 1 is caused by a mutation in GLRA 1 gene [3]. Delayed developmental milestones or learning difficulties can be observed in some children. Congenital disabilities leading to dysfunction of glycinergic inhibitory transmission are seen in hereditary hyperekplexia [4,5]. They are frequently associated with inguinal, umbilical, or epigastric hernias. As a rare disease, limited literature is available regarding anesthetic management in such cases, primarily when associated with congenital heart disease (CHD). Here, we discuss the successful management of a hyperekplexic child with CHD. Written informed consent to publish this case was obtained from the patient’s legal guardian. A 1-year-old child weighing 9 kg was scheduled for a right inguinal hernia repair surgery. At presentation, the patient had dysmorphic facial features (short nose, retrognathia, anteverted nares, and long philtrum) (Fig. 1). His medical history suggested that he was born by caesarean section (because of thick meconium-stained liquor). The patient’s birth history was uneventful. However, a few hours after birth, he presented with a flexed posture, brisk reflexes, and an exaggerated startle response and was diagnosed with hyperekplexia. At one month of age, he developed global hypertonia, and had delayed development. Electroencephalography revealed interictal epileptiform discharges originating from the left posterior head region. Electromyography revealed a myopathic potential. Magnetic resonance imaging results Letter to the Editor Anesth Pain Med 2022;17:338-339 https://doi.org/10.17085/apm.22173 pISSN 1975-5171 • eISSN 2383-7977","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"338-339"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5d/35/apm-22173.PMC9346195.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40576571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anesthetic management of cesarean delivery of parturient with systemic lupus erythematosus associated with pulmonary arterial hypertension - A case report. 系统性红斑狼疮合并肺动脉高压患者剖宫产的麻醉处理1例。
Pub Date : 2022-07-01 Epub Date: 2022-04-19 DOI: 10.17085/apm.21123
Saranya Lertkovit, Patchareya Nivatpumin

Background: Pulmonary hypertension in pregnancy is rare and leads to high maternal morbidity and mortality.

Case: A 27-year-old parturient woman with a 31-week gestational age underwent cesarean delivery under combined spinal-epidural anesthesia. She had systemic lupus erythematosus associated with severe pulmonary arterial hypertension. The operation was done in the cardiac theatre along with meticulous invasive monitoring. Insertion of femoral artery and femoral vein catheters for veno-arterial extracorporeal membrane oxygenation was done before delivery as preparation for the potential emergency of a life-threatening form of decompensated cardiac failure. During the delivery, the patient suddenly developed increased pulmonary arterial pressure. This was controlled by the continuous infusion of intravenous milrinone.

Conclusions: We report the successful management of this patient in the perioperative period. For cases such as that reported here, we recommend multidisciplinary team collaboration coupled with invasive cardiovascular monitoring and scrupulous anesthetic management.

背景:妊娠期肺动脉高压是一种罕见的疾病,其发病率和死亡率都很高。病例:一位27岁孕龄31周的孕妇在脊髓-硬膜外联合麻醉下剖宫产。她患有系统性红斑狼疮并伴有严重的肺动脉高压。手术是在心脏手术室进行的,并进行了细致的有创监测。在分娩前插入股动脉和股静脉导管进行静脉-动脉体外膜氧合,为潜在的危及生命的失代偿性心力衰竭的紧急情况做准备。在分娩过程中,患者突然出现肺动脉压升高。这是通过持续静脉滴注米力农控制的。结论:我们报告了该患者围手术期的成功治疗。对于这里报道的病例,我们建议多学科团队合作,结合侵入性心血管监测和严格的麻醉管理。
{"title":"Anesthetic management of cesarean delivery of parturient with systemic lupus erythematosus associated with pulmonary arterial hypertension - A case report.","authors":"Saranya Lertkovit,&nbsp;Patchareya Nivatpumin","doi":"10.17085/apm.21123","DOIUrl":"https://doi.org/10.17085/apm.21123","url":null,"abstract":"<p><strong>Background: </strong>Pulmonary hypertension in pregnancy is rare and leads to high maternal morbidity and mortality.</p><p><strong>Case: </strong>A 27-year-old parturient woman with a 31-week gestational age underwent cesarean delivery under combined spinal-epidural anesthesia. She had systemic lupus erythematosus associated with severe pulmonary arterial hypertension. The operation was done in the cardiac theatre along with meticulous invasive monitoring. Insertion of femoral artery and femoral vein catheters for veno-arterial extracorporeal membrane oxygenation was done before delivery as preparation for the potential emergency of a life-threatening form of decompensated cardiac failure. During the delivery, the patient suddenly developed increased pulmonary arterial pressure. This was controlled by the continuous infusion of intravenous milrinone.</p><p><strong>Conclusions: </strong>We report the successful management of this patient in the perioperative period. For cases such as that reported here, we recommend multidisciplinary team collaboration coupled with invasive cardiovascular monitoring and scrupulous anesthetic management.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"291-297"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9b/94/apm-21123.PMC9346200.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40576565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of anesthesia type on post-reperfusion syndrome during liver transplantation: a single-center retrospective study. 麻醉类型对肝移植术后再灌注综合征影响的单中心回顾性研究
Pub Date : 2022-07-01 Epub Date: 2022-04-08 DOI: 10.17085/apm.21104
Hye-Yeon Cho, Ho-Jin Lee, Won Ho Kim, Hyung-Chul Lee, Chul-Woo Jung, Suk Kyun Hong, Seong-Mi Yang

Background: Post-reperfusion syndrome (PRS) results in sudden hemodynamic instability following graft reperfusion. Although PRS is known to influence outcomes following liver transplantation, little is known regarding the effects of anesthetics on PRS. This study investigated the association between the type of anesthetic agent and PRS in liver transplantation.

Methods: This single-center retrospective cohort study included patients who underwent liver transplantation between June 2016 and December 2019. Patients were divided into sevoflurane and propofol groups according to the anesthetic agent used. Stabilized inverse probability of treatment weighting (IPTW) analysis was performed to investigate the association between PRS identified based on blood pressure recordings and the type of anesthesia. Associations between the anesthetic agent and the duration of hypotension as well as early postoperative outcomes were also investigated.

Results: Data were analyzed for 398 patients, 304 (76.4%) and 94 (23.6%) of whom were anesthetized with propofol and sevoflurane, respectively. PRS developed in 40.7% of the 398 patients. Following stabilized IPTW analysis, the association with PRS was lower in the sevoflurane group than in the propofol group (odds ratio, 0.47; P = 0.018). However, there was no association between the type of anesthetic used and early postoperative outcomes.

Conclusions: The association of PRS was lower in the sevoflurane group than in the propofol group. However, there was no association between the type of anesthetic and the early postoperative outcomes. Further studies are required to determine the optimal anesthetic for liver transplantation.

背景:再灌注后综合征(PRS)导致移植物再灌注后突然的血流动力学不稳定。虽然已知PRS会影响肝移植后的预后,但麻醉剂对PRS的影响知之甚少。本研究探讨了肝移植中麻醉药物类型与PRS的关系。方法:该单中心回顾性队列研究纳入了2016年6月至2019年12月期间接受肝移植的患者。根据麻醉药物的不同分为七氟醚组和异丙酚组。采用稳定治疗加权逆概率(IPTW)分析,探讨根据血压记录确定的PRS与麻醉类型之间的关系。还研究了麻醉剂与低血压持续时间以及术后早期结果之间的关系。结果:对398例患者进行数据分析,其中异丙酚麻醉304例(76.4%),七氟醚麻醉94例(23.6%)。398例患者中有40.7%出现PRS。经稳定IPTW分析,七氟醚组与PRS的相关性低于异丙酚组(优势比,0.47;P = 0.018)。然而,使用的麻醉药类型与早期术后结果之间没有关联。结论:七氟醚组PRS的相关性低于异丙酚组。然而,麻醉类型与早期术后结果之间没有关联。需要进一步的研究来确定肝移植的最佳麻醉剂。
{"title":"Influence of anesthesia type on post-reperfusion syndrome during liver transplantation: a single-center retrospective study.","authors":"Hye-Yeon Cho,&nbsp;Ho-Jin Lee,&nbsp;Won Ho Kim,&nbsp;Hyung-Chul Lee,&nbsp;Chul-Woo Jung,&nbsp;Suk Kyun Hong,&nbsp;Seong-Mi Yang","doi":"10.17085/apm.21104","DOIUrl":"https://doi.org/10.17085/apm.21104","url":null,"abstract":"<p><strong>Background: </strong>Post-reperfusion syndrome (PRS) results in sudden hemodynamic instability following graft reperfusion. Although PRS is known to influence outcomes following liver transplantation, little is known regarding the effects of anesthetics on PRS. This study investigated the association between the type of anesthetic agent and PRS in liver transplantation.</p><p><strong>Methods: </strong>This single-center retrospective cohort study included patients who underwent liver transplantation between June 2016 and December 2019. Patients were divided into sevoflurane and propofol groups according to the anesthetic agent used. Stabilized inverse probability of treatment weighting (IPTW) analysis was performed to investigate the association between PRS identified based on blood pressure recordings and the type of anesthesia. Associations between the anesthetic agent and the duration of hypotension as well as early postoperative outcomes were also investigated.</p><p><strong>Results: </strong>Data were analyzed for 398 patients, 304 (76.4%) and 94 (23.6%) of whom were anesthetized with propofol and sevoflurane, respectively. PRS developed in 40.7% of the 398 patients. Following stabilized IPTW analysis, the association with PRS was lower in the sevoflurane group than in the propofol group (odds ratio, 0.47; P = 0.018). However, there was no association between the type of anesthetic used and early postoperative outcomes.</p><p><strong>Conclusions: </strong>The association of PRS was lower in the sevoflurane group than in the propofol group. However, there was no association between the type of anesthetic and the early postoperative outcomes. Further studies are required to determine the optimal anesthetic for liver transplantation.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"304-311"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c3/f9/apm-21104.PMC9346196.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40576567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Anesthesia and pain medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1